Xuezhi Du

Statistics

Publications

Citations

240

H-Index

Active since

2020

Affiliations

Tianjin Medical University General Hospital(Current)

Tianjin Medical University

First Affiliated Hospital of Zhengzhou University

Zhejiang University

Second Hospital of Tianjin Medical University

Xuezhi Du is an author at Tianjin Medical University General Hospital specializing in heart transplant rejection, molecular oncology, and transplant immunology.

ORCID

Publications per year

2020–2022

Publications

Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas

Cheng Wei, Bo Wang, Dazhao Peng et al. · Frontiers in Immunology · 2022 · 103 citations · Full text

Medicine, Molecular Biology, Oncology +17

LncRNA HOXA11-AS promotes glioma malignant phenotypes and reduces its sensitivity to ROS via Tpl2-MEK1/2-ERK1/2 pathway

Cheng Wei, Xiaoyang Zhang, Dazhao Peng et al. · Cell Death and Disease · 2022 · 42 citations · Full text

Medicine, Cancer Biology, Oncology +14

Mesenchymal stem cells transfected with sFgl2 inhibit the acute rejection of heart transplantation in mice by regulating macrophage activation

Chao Gao, Xiaodong Wang, Jian Lu et al. · Stem Cell Research & Therapy · 2020 · 27 citations · Full text

Life Sciences, Biomedical Sciences, Immunology +16

The lncRNA PVT1 regulates autophagy in regulatory T cells to suppress heart transplant rejection in mice by targeting miR-146a

Jian Lu, Xiaodong Wang, Baotong Zhang et al. · Cellular Immunology · 2021 · 25 citations

Life Sciences, Immunology, Molecular Biology +16

MiR-146a regulates regulatory T cells to suppress heart transplant rejection in mice

Jian Lu, Weiwei Wang, Peiyuan Li et al. · Cell Death Discovery · 2021 · 23 citations · Full text

Life Sciences, Cell Biology, Immunology +17

1–5 of 6